Last reviewed · How we verify
NCT04655079: STIM-PSP
Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) in Progressive Supranuclear Palsy (PSP) (STIM-PSP)
NA trial testing Anodal transcranial direct current stimulation (a-tDCS) in Progressive Supranuclear Palsy in 24 participants. Completed in 11 May 2022.
11 May 2022
Quick facts
| Lead sponsor | University of Salerno |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 February 2021 |
| Primary completion | 11 May 2022 |
| Estimated completion | 11 May 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Anodal transcranial direct current stimulation (a-tDCS)
- Sham Condition
Conditions studied
- Progressive Supranuclear Palsy — all drugs for Progressive Supranuclear Palsy →
- Motor and Cognitive Symptoms — all drugs for Motor and Cognitive Symptoms →
Sponsor
University of Salerno
Who can join
Adults 40 to 89, any sex, with Progressive Supranuclear Palsy or Motor and Cognitive Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) on cognitive and motor symptoms in Progressive Supranuclear Palsy (PSP) over the left dorsolateral prefrontal cortex (dlPFC).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review.
Dunning EE, Decourt B, Zawia NH, Shill HA, et al · · 2024 · cited 2× · PMID 38743312 · DOI 10.1007/s40120-024-00614-9
Verify or expand the search:
- PubMed search for NCT04655079
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Progressive Supranuclear Palsy
Currently open trials in the same condition.
- NCT06588673 — Art Therapy in Progressive Supranuclear Palsy · NA · active not recruiting
- NCT06647641 — The CurePSP Genetics Program · recruiting
- NCT06174948 — The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders · NA · recruiting
- NCT06122662 — AMX0035 and Progressive Supranuclear Palsy · Phase 2, PHASE3 · active not recruiting
- NCT05956834 — A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes · active not recruiting
Other University of Salerno trials
Trials by the same sponsor.
- NCT06909682 — AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices · recruiting
- NCT07023536 — Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure · recruiting
- NCT06381947 — Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients · Phase 4 · not yet recruiting
- NCT06589063 — Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis · recruiting
- NCT05854342 — Evaluation of the Effects of Bicarbonate-calcium Water in Premenopausal and Postmenopausal Women as a Prevention of Oste · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04655079 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Salerno
- Last refreshed: 2 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04655079.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing